Boston Scientific Corporation (BSX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 348M | 1.36B | 1.34B | 1.29B | 541M | 1.46B | 1B | 813M | 164M | 957M | 698M | 658M |
| Operating CF Margin % | 6.69% | 25.8% | 26.52% | 25.41% | 11.6% | 31.92% | 23.81% | 19.73% | 4.25% | 25.69% | 19.79% | 18.28% |
| Operating CF Growth % | -35.67% | -6.32% | 34.03% | 58.18% | 229.88% | 52.14% | 43.55% | 23.56% | -13.68% | 18.59% | 48.2% | 115.03% |
| Net Income | 1.34B | 672M | 755M | 795M | 672M | 562M | 700M | 324M | 493M | 504M | 504M | 270M |
| Depreciation & Amortization | 351M | 365M | 342M | 336M | 325M | 348M | 636M | 311M | 304M | 313M | 300M | 298M |
| Stock-Based Compensation | 0 | 0 | 79M | 75M | 74M | 69M | -61M | 195M | 63M | 59M | 59M | 60M |
| Deferred Taxes | -351M | -22M | 69M | -90M | 41M | -80M | -11M | -10M | 31M | 73M | -29M | -64M |
| Other Non-Cash Items | -78M | 194M | 54M | -63M | 107M | 233M | -428M | 202M | 16M | 65M | 40M | 108M |
| Working Capital Changes | -915M | 155M | 44M | 233M | -678M | 324M | 166M | -209M | -743M | -57M | -176M | -14M |
| Change in Receivables | -117M | -98M | -32M | -32M | -107M | 52M | -33M | -114M | -114M | -74M | -3M | -75M |
| Change in Inventory | -177M | -50M | -94M | 65M | -109M | 46M | -55M | -95M | -124M | -59M | -202M | -214M |
| Change in Payables | -512M | 285M | 165M | 231M | -385M | 385M | 237M | 71M | -450M | 23M | 17M | 289M |
| Cash from Investing | -591M | -512M | -502M | -1.13B | -500M | -3.7B | -1.43B | -271M | -285M | -1.05B | -197M | -840M |
| Capital Expenditures | -177M | -351M | -181M | -157M | -187M | -277M | -179M | -155M | -179M | -267M | -206M | -206M |
| CapEx % of Revenue | 3.4% | 6.64% | 3.57% | 3.1% | 4.01% | 6.07% | 4.25% | 3.76% | 4.64% | 7.17% | 5.84% | 5.72% |
| Acquisitions | -523M | -89M | -256M | -1.01B | -239M | -3.42B | -1.13B | -48M | -47M | -793M | 1M | -643M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 48M | 2M | -65M | 40M | -74M | -9M | -121M | 5M | 7M | 7M | 9M | 70M |
| Cash from Financing | -260M | -184M | -104M | -340M | 233M | 214M | 7M | 24M | 1.57B | 15M | 16M | 43M |
| Debt Issued (Net) | -259M | -405M | -19M | -314M | 247M | 189M | 22M | 0 | 1.62B | 0 | -41M | 37M |
| Equity Issued (Net) | 81M | 20M | 115M | 32M | 115M | 28M | 96M | 26M | 80M | 17M | 75M | 27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -23M | 0 | 0 | 0 | 0 | -14M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80M | 0 | 0 | 0 |
| Other Financing | -82M | 201M | -200M | -58M | -129M | -3M | -88M | -2M | -127M | -2M | -18M | -7M |
| Net Change in Cash | -521M | 672M | 730M | -178M | 313M | -2.04B | -413M | 566M | 1.44B | -77M | 512M | -144M |
| Free Cash Flow | 171M | 1.01B | 1.16B | 1.1B | 354M | 1.16B | 698M | 658M | -81M | 690M | 492M | 452M |
| FCF Margin % | 3.29% | 19.16% | 22.94% | 21.66% | 7.59% | 25.5% | 16.58% | 15.97% | -2.1% | 18.52% | 13.95% | 12.56% |
| FCF Growth % | -51.69% | -12.9% | 66.48% | 66.57% | 537.04% | 68.55% | 41.87% | 45.58% | -217.39% | 13.67% | 65.1% | 123.76% |
| FCF per Share | 0.11 | 0.68 | 0.78 | 0.73 | 0.24 | 0.78 | 0.47 | 0.44 | -0.05 | 0.47 | 0.33 | 0.31 |
| FCF Conversion (FCF/Net Income) | 0.26x | 2.04x | 1.78x | 1.62x | 0.80x | 2.57x | 2.14x | 2.51x | 0.33x | 1.90x | 1.38x | 2.44x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |